Telomere Length and the Clinical Phenotype of Frailty in Older Adults Undergoing Cardiac Surgery

Journal of the American Geriatrics Society

Volumn 62, Issue 11, 2014, Pages 2205-2207

  Brault, Marie Eve ^a,b   Ohayon, Samuel M ^c   Kwan, Ricky ^c   Bergman, Howard ^a   Eisenberg, Mark J ^c,d   Boivin, Jean François ^d   Morin, Jean François ^d   Langlois, Yves ^d   Autexier, Chantal ^a,b,c   Afilalo, Jonathan ^c,d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; FRAIL ELDERLY; GRIP STRENGTH; HEART SURGERY; HUMAN; INVASIVE PROCEDURE; KIDNEY FAILURE; LETTER; LEUKOCYTE; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PHENOTYPE; SURGICAL MORTALITY; COHORT ANALYSIS; FEASIBILITY STUDY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; HEALTH STATUS INDICATOR; HEART DISEASES; LENGTH OF STAY; MALE; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; STATISTICS AND NUMERICAL DATA; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; VERY ELDERLY;

GENETIC MARKER;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEASIBILITY STUDIES; FRAIL ELDERLY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS INDICATORS; HEART DISEASES; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; PHENOTYPE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING;

EID: 84922482135     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13076     Document Type: Letter

References (10)

1. Afilalo J, Karunananthan S, Eisenberg MJ, et al., Role of frailty in patients with cardiovascular disease. Am J Cardiol 2009; 103: 1616-1621.
2. Afilalo J, Eisenberg MJ, Morin J-F, et al., Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol 2010; 56: 1668-1676.
3. Fried LP, Tangen CM, Walston J, et al., Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56A: 146-156.
4. Cawthon RM, Smith KR, O'Brien E, et al., Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361: 393-395.
5. Woo J, Tang NLS, Suen E, et al., Telomeres and frailty. Mech Ageing Dev 2008; 129: 642-648.
6. Collerton J, Martin-Ruiz C, Davies K, et al., Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: Cross-sectional findings from the Newcastle 85+ Study. Mech Ageing Dev 2012; 133: 456-466.
7. Ponsot E, Lexell J, Kadi F,. Skeletal muscle telomere length is not impaired in healthy physically active old women and men. Muscle Nerve 2008; 37: 467-472.
8. Chang E, Harley CB,. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci U S A 1995; 92: 11190-11194.
9. Aviv A, Valdes AM, Spector TD,. Human telomere biology: Pitfalls of moving from the laboratory to epidemiology. Int J Epidemiol 2006; 35: 1424-1429.
10. von Zglinicki T,. Oxidative stress shortens telomeres. Trends Biochem Sci 2002; 27: 339-344.